Alcohol-related harms contribute substantially to the burden of disease in Australia, with a wide range of acute and chronic consequences associated with alcohol consumption.
This project builds on research by Professor Donald Tashkin (University of California) to further extend the message on respiratory cannabis-related harms.
Individuals often report using cannabis to sleep, experiencing sleep problems as a symptom of withdrawal, and relapsing due to sleep problems.
Workplace substance use incurs substantial costs to society and employers through decreased workplace productivity as well as increased employee turnover, absenteeism and worker stress.
The Reference Group to the United Nations on HIV and Injecting Drug Use was established in 2002 and provides independent advice to the United Nations system on matters related to injecting drug use and HIV.
The Global Burden of Disease (GBD) project provides comprehensive and comparable data on mortality and loss of health due to diseases, injuries and risk factors for all regions of the world.
Alcohol consumption is strongly linked to premature mortality. This study aims to characterise sudden or unnatural deaths with very high range blood alcohol concentrations that presented to the Department of Forensic Medicine in Sydney between 1997-2011.
There is little detailed information about the Australian cannabis market, including the chemical characteristics of the locally available cannabis product.
Over three million Australians have a lifetime alcohol use disorder and one in five will have co-occurring major depression in the last year.
The Illicit Drug Reporting System (IDRS) is a national illicit drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets.
